Joint Formulary & PAD

Phenobarbital - Epilepsy

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Elixir
  • Tablets
Associated Icons :
BNF SPC
CD
Restrictions / Comments :
 

Status 2

Blue
Formulations :
  • Liquid
Associated Icons :
BNF SPC
CD
Un
Restrictions / Comments :
Important
Unlicensed phenobarbital liquid 50mg/5ml (sugar and alcohol free) for paediatric use (as recommended by the RCPCH and NPPG).

PAD Profile

ChemicalSubstance :
Phenobarbital
Indication :
Epilepsy
Group Name :
Keywords :
Brand Names Include :
Important Information :
Ensure that the patient is maintained on a specific manufacturer’s product
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
3
Traffic Light Entries :
2

Other Indications

Below are listed other indications that Phenobarbital is used to treat.

Committee Recommendations (1)

he PCN supported the principles of switching from brand to generic medications (not recommended in the elderly) as per national guidelines in September 2013 and the proposed place in therapy of the anti-epileptic drugs which is based on NICE guidance was also discussed at that time. Transfer of care documents will be considered at a future PCN.

Please note the MHRA categorisations for each drug in the attached guidance (updated January 2014) and in the link below.